(Q38568853)

4 September 2017

title

miRNA for diagnosis and clinical implications of human hepatocellular carcinoma (English)

1 reference

4 September 2017

Yurong Wang

1

1 reference

4 September 2017

Yaping Tian

series ordinal

2

1 reference

4 September 2017

publication date

18 August 2015

1 reference

4 September 2017

1 reference

4 September 2017

volume

46

1 reference

4 September 2017

issue

1

1 reference

4 September 2017

page(s)

89-99

1 reference

Global cancer statistics, 2012

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Risk factors for hepatocellular carcinoma may impair the performance of biomarkers: a comparison of AFP, DCP, and AFP-L3

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Serum microRNA 143 and microRNA 215 as potential biomarkers for the diagnosis of chronic hepatitis and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Recurrence predictive models for patients with hepatocellular carcinoma after radiofrequency ablation using support vector machines with feature selection methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

MicroRNA-101 suppresses SOX9-dependent tumorigenicity and promotes favorable prognosis of human hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

A quantitative PCR method to detect blood microRNAs associated with tumorigenesis in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Promising Candidate Urinary MicroRNA Biomarkers for the Early Detection of Hepatocellular Carcinoma among High-Risk Hepatitis C Virus Egyptian Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Hepatocellular carcinoma: epidemiology, risk factors, and screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

The nuclear RNase III Drosha initiates microRNA processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

An mRNA m7G cap binding-like motif within human Ago2 represses translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

MicroRNA profile predicts recurrence after resection in patients with hepatocellular carcinoma within the Milan Criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

A small-molecule modulator of the tumor-suppressor miR34a inhibits the growth of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Downregulation of microRNA-214 and overexpression of FGFR-1 contribute to hepatocellular carcinoma metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Ectopic expression of MiR-125a inhibits the proliferation and metastasis of hepatocellular carcinoma by targeting MMP11 and VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Effects of microRNA-30a on migration, invasion and prognosis of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Expression of serum exosomal microRNA-21 in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Hypomethylation of the hsa-miR-191 locus causes high expression of hsa-mir-191 and promotes the epithelial-to-mesenchymal transition in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Identification of metastasis-related microRNAs in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Hepatocellular carcinoma development in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Mechanisms of hepatic fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Molecular mechanism and treatment of viral hepatitis-related liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Epigenetic regulation of connective tissue growth factor by MicroRNA-214 delivery in exosomes from mouse or human hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

The autoregulatory feedback loop of microRNA-21/programmed cell death protein 4/activation protein-1 (MiR-21/PDCD4/AP-1) as a driving force for hepatic fibrosis development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

microRNA-222 modulates liver fibrosis in a murine model of biliary atresia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Profibrotic effect of miR-33a with Akt activation in hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Expression and significance of microRNA-183 in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Up-regulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

ANT2 suppression by shRNA restores miR-636 expression, thereby downregulating Ras and inhibiting tumorigenesis of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Cyclooxygenase-2 is a target of microRNA-16 in human hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Expression and clinicopathological significance of miR-146a in hepatocellular carcinoma tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Genome-wide screening identified that miR-134 acts as a metastasis suppressor by targeting integrin β1 in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

HCV core protein-induced down-regulation of microRNA-152 promoted aberrant proliferation by regulating Wnt1 in HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Peroxisome proliferator-activated receptor alpha regulates a microRNA-mediated signaling cascade responsible for hepatocellular proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Let-7g targets collagen type I alpha2 and inhibits cell migration in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

MicroRNAs involved in neoplastic transformation of liver cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

MicroRNA-21-3p, a berberine-induced miRNA, directly down-regulates human methionine adenosyltransferases 2A and 2B and inhibits hepatoma cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

MicroRNA-22 expression in hepatocellular carcinoma and its correlation with ezrin protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

MicroRNA-124 suppresses growth of human hepatocellular carcinoma by targeting STAT3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

MicroRNA-142-3p, a new regulator of RAC1, suppresses the migration and invasion of hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

MicroRNA-520c-3p inhibits hepatocellular carcinoma cell proliferation and invasion through induction of cell apoptosis by targeting glypican-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

MiR-181a-5p is downregulated in hepatocellular carcinoma and suppresses motility, invasion and branching-morphogenesis by directly targeting c-Met

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

miR-376a suppresses proliferation and induces apoptosis in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Retinoic acid induced 16 enhances tumorigenesis and serves as a novel tumor marker for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Autophagy suppresses tumorigenesis of hepatitis B virus-associated hepatocellular carcinoma through degradation of microRNA-224.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Clinical significance of miR-221 and its inverse correlation with p27Kip¹ in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Increased miR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

miR-221 overexpression contributes to liver tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

MicroRNA-21 promotes hepatocellular carcinoma HepG2 cell proliferation through repression of mitogen-activated protein kinase-kinase 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

miR-183 inhibits TGF-beta1-induced apoptosis by downregulation of PDCD4 expression in human hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Stat3-mediated activation of microRNA-23a suppresses gluconeogenesis in hepatocellular carcinoma by down-regulating glucose-6-phosphatase and peroxisome proliferator-activated receptor gamma, coactivator 1 alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

The expression level of miR-18b in hepatocellular carcinoma is associated with the grade of malignancy and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

A serum microRNA panel as potential biomarkers for hepatocellular carcinoma related with hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Exploration of genome-wide circulating microRNA in hepatocellular carcinoma: MiR-483-5p as a potential biomarker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Serum miR-18a: a potential marker for hepatitis B virus-related hepatocellular carcinoma screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

A genetic variant in the promoter region of miR-106b-25 cluster predict clinical outcome of HBV-related hepatocellular carcinoma in Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

A potentially functional polymorphism in the promoter region of let-7 family is associated with survival of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Promoter polymorphisms of pri-miR-34b/c are associated with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Identification of recurrence related microRNAs in hepatocellular carcinoma after surgical resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

MicroRNA-29a-5p is a novel predictor for early recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

miR-203 expression predicts outcome after liver transplantation for hepatocellular carcinoma in cirrhotic liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

miR-675 mediates downregulation of Twist1 and Rb in AFP-secreting hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Upregulation of microRNA-25 associates with prognosis in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12571

21 January 2018

Identifiers

DOI

10.1111/HEPR.12571

1 reference

4 September 2017

1 reference